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Background: Although Korean Red Ginseng (KRG) has been traditionally used for a long time, its anti-
inﬂammatory role and underlying molecular and cellular mechanisms have been poorly understood.
In this study, the anti-inﬂammatory roles of KRG-derived components, namely, water extract (KRG-WE),
saponin fraction (KRG-SF), and nonsaponin fraction (KRG-NSF), were investigated.
Methods: To check saponin levels in the test fractions, KRG-WE, KRG-NSF, and KRG-SF were analyzed
using high-performance liquid chromatography. The anti-inﬂammatory roles and underlying cellular and
molecular mechanisms of these components were investigated using a macrophage-like cell line
(RAW264.7 cells) and an acute gastritis model in mice.
Results: Of the tested fractions, KGR-SF (but not KRG-NSF and KRG-WE) markedly inhibited the viability
of RAW264.7 cells, and splenocytes at more than 500 mg/mL signiﬁcantly suppressed NO production at
100 mg/mL, diminished mRNA expression of inﬂammatory genes such as inducible nitric oxide synthase,
cyclooxygenase-2, tumor necrosis factor-a, and interferon-b at 200 mg/mL, and completely blocked
phagocytic uptake by RAW264.7 cells. All three fractions suppressed luciferase activity triggered by
interferon regulatory factor 3 (IRF3), but not that triggered by activator protein-1 and nuclear factor-
kappa B. Phospho-IRF3 and phospho-TBK1 were simultaneously decreased in KRG-SF. Interestingly, all
these fractions, when orally administered, clearly ameliorated the symptoms of gastric ulcer in HCl/
ethanol-induced gastritis mice.
Conclusion: These results suggest that KRG-WE, KRG-NSF, and KRG-SF might have anti-inﬂammatory
properties, mostly because of the suppression of the IRF3 pathway.
Copyright  2016, The Korean Society of Ginseng, Published by Elsevier. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Inﬂammation is an innate immune response consisting of a
series of complex biological processes to protect the body from
infection by pathogens, including bacteria, viruses, and fungi [1,2].
Inﬂammation is characterized by key symptoms, including
recruitment of white blood cells, pain, redness, swelling, heat, tis-
sue damage, and organ dysfunction. During the inﬂammatory
response, different types of immune cells are actively recruited to
the inﬂamed lesions to remove the invading pathogens. Amonggineering, Sungkyunkwan Universi
College of Veterinary Medicine, C
m1@chonbuk.ac.kr (J.-H. Kim).
ht  2016, The Korean Society of G
d/4.0/).these immune cells, the macrophage is one of the major effector
cells governing inﬂammatory responses by producing various in-
ﬂammatory mediators, including nitric oxide (NO), reactive oxy-
gen/nitrogen species (ROS/RNS), prostaglandin E2 (PGE2), and
different types of proinﬂammatory cytokines. The latter include
tumor necrosis factor (TNF)-a, interleukin (IL)-1b, IL-6 [under the
control of the activator protein (AP)-1], nuclear factor kappa B (NF-
kB), and interferon (IFN) regulatory factor 3 (IRF3) [2e7]. Although
inﬂammation is a host defensemechanism to protect the body from
invading pathogens, chronic inﬂammation, which is a prolongedty, 2066 Seobu-ro, Jangan-gu, Suwon 16419, Korea.
honbuk National University, 79 Gobong-ro, Iksan 54596, Korea.
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Table 1
Primer sequences used for semiquantitative PCR
Name Sequence (50 to 30)
iNOS F CCCTTCCGAAGTTTCTGGCAGCAG
R GGCTGTCAGAGCCTCGTGGCTTTGG
COX-2 F CACTACATCCTGACCCACTT
R ATGCTCCTGCTTGAGTATGT
TNF-a F TTGACCTCAGCGCTGAGTTG
R CCTGTAGCCCACGTCGTAGC
IFN-b F CAGGATGAGGACATGAGCACC
R CTCTGCAGACTCAAACTCCAC
GAPDH F CACTCACGGCAAATTCAACGGCA
R GACTCCACGACATACTCAGCAC
COX-2, cyclooxygenase-2; GAPDH, glyceraldehyde 3-phosphate dehydrogenase;
IFN-b, interferon beta; iNOS, inducible nitric oxide synthase; PCR, polymerase chain
reaction; TNF-a, tumor necrosis factor alpha
J Ginseng Res 2016;40:437e444438state affecting tissue remodeling for several weeks to years, is
regarded as a leading cause in the development of a variety of
diseases, such as inﬂammatory/autoimmune diseases, neurode-
generative diseases, and cancers [8e10].
Korean ginseng (Panax ginseng) is a perennial plant that has
been traditionally used as an herbal medicine to ameliorate the
symptoms of various diseases in eastern Asia. The ginseng root has
been used as a common ethnopharmacological remedy to support
vitality [11,12]. Because fresh ginseng is easily degraded at room
temperature, it needs to be processed to red ginseng by steaming
and drying, and accumulating evidence has revealed that red
ginseng has higher biological activity and lower side effects
compared to fresh or white ginseng [13]. Korean Red Ginseng (KRG)
has been known to have various biological activities, including
immune enhancement, antioxidant effects, memory enhancement,
improvement of menopausal disorder, and induction of metabolic
energy [14e17]. However, although KRG has been studied in human
health and immunity, the therapeutic potential of each component
derived from KRG extract in modulating inﬂammatory responses
and in preventing inﬂammatory diseases has been poorly
understood.
Therefore, in this study, we prepared three fractions of
KRGdwater extract (KRG-WE), nonsaponin fraction (KRG-NSF),
and saponin fraction (KRG-SF)dand investigated their therapeutic
potency in inﬂammatory responses and diseases using lipopoly-
saccharide (LPS)-stimulated macrophages and an acute inﬂamma-
tory gastritis mouse model.2. Materials and methods
2.1. Materials
KRG-WE, KRG-NSF, and KRG-SF were kindly supplied by the
Korea Ginseng Corporation (Daejeon, Korea). Male imprinting
control region (ICR) mice (6e8 wk old, 17e21 g) were purchased
from Orient Bio (Gyeonggi, Korea). RAW264.7 and HEK293 cells
were purchased from the American Type Culture Collection
(Manassas, VA, USA). Dulbecco’s modiﬁed Eagle’s medium, Roswell
Park Memorial Institute 1640 (RPMI 1640) medium, fetal bovine
serum (FBS), streptomycin, penicillin, and L-glutamine were pur-
chased fromGibco (Grand Island, NY, USA). LPS, Nu-nitro-L-arginine
methyl ester (L-NAME), 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT), polyethylenimine (PEI), ra-
nitidine (RNT), and ﬂuorescein isothiocyanate (FITC)-dextran were
purchased from Sigma (St. Louis, MO, USA). The primers used for
semiquantitative reverse transcription-polymerase chain reaction
(RT-PCR) were synthesized, and PCR premix was purchased from
Bioneer Inc. (Daejeon, Korea). Constructs expressing signaling
proteins (FLAG-MyD88 and FLAG-TBK1) and luciferase constructs
containing the binding promoters for NF-kB, AP-1, and IFN-b were
used as previously reported [18,19]. Antibodies used in this study
were purchased from Cell Signaling Technology (Beverly, MA, USA).
The luciferase assay system was purchased from Promega (Madi-
son, WI, USA).2.2. Mice
Male ICR mice (6e8 wk old, 17e21 g) were obtained fromOrient
Bio (Gyeonggi, Korea) and maintained in plastic cages under stan-
dard conditions. Water and pelleted food (Samyang, Daejeon, Ko-
rea) were supplied ad libitum. Studies were performed in
accordance with the guidelines established by the Institutional
Animal Care and Use Committee at Sungkyunkwan University,
Suwon, Korea.2.3. Preparation of splenocytes from mice
Splenocytes from ICR mice were prepared as previously
described [20].
2.4. Cell culture
RAW264.7, HEK293 cells and splenocytes were cultured in RPMI
1640 medium supplemented with 10% heat-inactivated FBS,
glutamine, and antibiotics (penicillin and streptomycin) at 37C in a
5% CO2 humidiﬁed incubator.
2.5. High-performance liquid chromatography analysis
For determination of ginsenosides from KRG-WE, KRG-SF, and
KRG-NSF, high-performance liquid chromatography (HPLC) was
conducted as described previously [21,22].
2.6. Cell viability assay
The cytotoxic effects of KRG-WE, KRG-SF, and KRG-NSF were
determined using the MTT assay, as reported previously [23].
2.7. Phagocytosis assay
RAW264.7 cells treatedwith KRG-WE, KRG-SF, or KRG-NSFwere
resuspended in 100 mL phosphate-buffered saline (PBS) containing
1% human AB serum and incubated with FITC-dextran (1 mg/mL) at
37C for 30 min. The incubations were stopped by adding 2 mL ice-
cold PBS containing 1% human serum and 0.02% sodium azide. The
cells were then washed three times with cold PBS-azide and
analyzed on a FACScan ﬂow cytometer, as reported previously [24].
2.8. NO production assay
RAW264.7 cells were pretreated with either KRG-WE, KRG-NSF,
or KRG-SF and incubated with LPS (1 mg/mL) for 24 h. NO produc-
tion level was determined using Griess reagent as described pre-
viously [25].
2.9. mRNA analysis by semiquantitative RT-PCR
RAW264.7 cells pretreated with KRG-WE, KRG-NSF, or KRG-SF
for 1 h were incubated with LPS (1 mg/mL) for 6 h. Total RNA was
isolated with TRI reagent according to the manufacturer’s in-
structions and stored at 70C until use. cDNA from 1 mg of total
RNA was synthesized using MuLV reverse transcriptase according
to the manufacturer’s instructions, and semiquantitative RT-PCR
Table 2
HPLC proﬁle of ginseng components from KRG-WE, KRG-NSF, and KRG-SF
(mg/g)
Rg1 Re Rf Rh1 Rg2s Rb1 Rc Rb2 Rd Rg3s Rg3r
KRG-WE 1.03 1.21 1.04 0.96 1.43 5.19 2.02 1.88 0.67 2.10 0.96
KRG-SF 13.33 15.68 13.39 11.54 15.75 64.20 25.98 22.96 8.29 21.69 10.60
KRG-NSF 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
HPLC, high-performance liquid chromatography; KRG-NSF, Korean Red Ginseng nonsaponin fraction; KRG-SF, Korean Red Ginseng saponin fraction; KRG-WE, Korean Red
Ginseng water extract
K.-S. Baek et al / Effects of KRG-derived components 439reactions were conducted using the primers speciﬁc for inducible
NO synthase (iNOS), cyclooxygenase (COX)-2, TNF-a, IFN-b, and
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as previously
reported [26]. The primer sequences used in this study are listed in
Table 1.
2.10. Luciferase reporter gene assay
HEK293 cells were transfected with b-galactosidase and NF-kB-
Luc, AP-1-Luc, IRF3-Luc, MyD88, or TBK1 using PEI. The cells were
treated with KRG-WE, KRG-NSF, or KRG-SF for 12 h prior to
termination. Luciferase assays were performed using the Luciferase
Assay System according to the manufacturer’s instructions (Prom-
ega, Madison, WI, USA).
2.11. Preparation of whole cell and nuclear lysates and Western blot
analysis
RAW264.7 cells were treatedwith KRG-WE, KRG-NSF, or KRG-SF
for the indicated time, and whole cell and nuclear lysates wereFig. 1. HPLC proﬁles. (A) KRG-WE. (B) KRG-SF. (C) KRG-NSF. HPLC, high-performance liquid c
Ginseng saponin fraction; KRG-WE, Korean Red Ginseng water extract.prepared as described previously [23]. Western blot analysis was
performed as previously reported [23] using the indicated
antibodies.
2.12. HCl/ethanol-induced gastritis in mice
Fasted ICR mice (7 mice/group) were orally treated with KRG-
WE, KRG-NSF, KRG-SF (200 mg/kg), or ranitidine (40 mg/kg)
twice daily for 3 d. At 30min after the ﬁnal administration, stomach
inﬂammation was induced by oral administration of HCl/ethanol
(EtOH), and the degree of inﬂammation was analyzed according to
a published method [27].
2.13. Statistical analysis
All data in this paper are presented as the mean  standard
deviation of an experiment performed with six or three replicates.
For statistical comparisons, these results were analyzed using
KruskaleWallis/ManneWhitney U tests. A p value < 0.05 was
considered statistically signiﬁcant. All statistical tests were carriedhromatography; KRG-NSF, Korean Rd Ginseng nonsaponin fraction; KRG-SF, Korean Red
J Ginseng Res 2016;40:437e444440out using the computer program SPSS (Version 22.0, 2013; IBM
Corp., Armonk, NY, USA).
3. Results and discussion
In this study, the regulatory roles of KRG-WE, KRG-NSF, and
KRG-SF in the inﬂammatory response were investigated using
macrophages and an inﬂammatory disease animal model. First, the
major active saponin components of KRG-WE, KRG-NSF, and KRG-
SFwere identiﬁed and analyzed byHPLC analysis. A variety of active
ginseng components, including ginsenoside (G)-Rg1, G-Re, G-Rf, G-
Rh1, G-Rg2s, G-Rb1, G-Rc, G-Rb2, G-Rd, G-Rg3s, and G-Rg3r were
identiﬁed in both KRG-WE and KRG-SF, in varying amounts
(Table 2), whereas none of them was found in KRG-NSF (Figs. 1Ae
1C). Along with ginseng components, amino acids and sugars were
also identiﬁed from KRG-WE, KRG-NSF, and KRG-SF in varying
amounts (data not shown). These HPLC analysis results indicate
that ginsenosides and their metabolites, known as the major active
pharmaceutical components of ginseng [28], are contained only in
KRG-WE and KRG-SF, but not in KRG-NSF.
To examine the cytotoxicity of KRG-WE, KRG-NSF, and KRG-SF in
macrophages prior to exploring their anti-inﬂammatory activities,
RAW264.7 cells were treated with KRG-WE, KRG-NSF, and KRG-SF,
and the cell viability was determined. As shown in Fig. 2A, KRG-WE
and KRG-NSF decreased the cell viability of RAW264.7 cells by 10e
20% with doses up to 800 mg/mL, whereas SF exerted signiﬁcant
cytotoxicity from 400 mg/mL (w80% decrease in viability) to 800 mg/
mL (>90% decrease in viability). Similarly, KRG-WE and KRG-NSF
did not show cytotoxicity in splenocyte culture, whereas SF
signiﬁcantly reduced splenocyte viability from 250 mg/mL (w40%)
up to 1,000 mg/mL (60%) (Fig. 2B). These results suggest that, unlike
KRG-NSF, KRG-SF has a severe cytotoxic effect at higher doses, and
ginsenosides that are contained only in KRG-SF are regarded as the
main contributors for this cytotoxicity. These data highlight the
importance of considering the optimal dose of KRG-SF or ginse-
nosides for their pharmaceutical use.
Inﬂammatory responses are characterized by the release of in-
ﬂammatory mediators such as NO and the expression of proin-
ﬂammatory cytokines such as TNF-a and IFN-b. Therefore, we
examined whether KRG-WE, KRG-NSF, and KRG-SF exert anti-
inﬂammatory effects in LPS-treated macrophages. First, NO levelsFig. 2. Effects of KRG-WE, KRG-NSF, and KRG-SF on cell viability. (A) RAW264.7 cells and (B
KRG-SF for 24 h, and the cell viabilities were determined by MTT assay. *p < 0.05, **p < 0.01
SF, Korean Red Ginseng saponin fraction; KRG-WE, Korean Red Ginseng water extract; MTTwere evaluated in the LPS-stimulated RAW264.7 cells after treating
them with KRG-WE, KRG-NSF, or KRG-SF. As shown in Fig. 3A, NO
production induced by LPS in RAW264.7 cells was markedly
decreased by KRG-SF in a dose-dependent manner (left panel),
consistent with the use of L-NAME, an iNOS inhibitor (right panel).
The effects of KRG-WE, KRG-NSF, and KRG-SF on the expression of
inﬂammatory genes were further examined in macrophages. The
mRNA expression levels of inﬂammatory genes such as iNOS, COX-
2, TNF-a, and IFN-b were determined by semiquantitative RT-PCR
in LPS-stimulated RAW264.7 cells after treating them with KRG-
WE, KRG-NSF, or KRG-SF. Induced expression of these genes in
LPS-stimulated RAW264.7 cells was signiﬁcantly decreased by
KRG-SF, whereas both KRG-WE and KRG-NSF did not exert sup-
pressive effects on the expression of these genes (Fig. 3B). These
results strongly indicate that KRG-SF, but not KRG-WE and KRG-
NSF, plays an anti-inﬂammatory role in macrophages through
suppressing the release and mRNA expression of inﬂammatory
mediators. The effects of KRG-WE, KRG-NSF, and KRG-SF on the
generation of ROS, which are representative inﬂammatory media-
tors produced inmacrophages, were also examined; however, none
of them suppressed ROS generation in LPS-stimulated RAW264.7
cells (data not shown). These results indicate that, although both
NO and ROS are inﬂammatorymediators produced inmacrophages,
themolecular mechanism bywhich SFmodulates the production of
NO and ROS in macrophages is different, and this needs to be
further investigated. The phagocytic activity of macrophages is
another indicator of macrophage activation, and the effect of KRG-
WE, KRG-NSF and KRG-SF on the phagocytic activity of macro-
phages was examined. As shown in Fig. 3C, only SF markedly
suppressed the phagocytic activity of RAW264.7 cells, whereas
KRG-WE and KRG-NSF only slightly decreased the phagocytic ac-
tivity. This suggests that KRG-SF may exhibit its anti-inﬂammatory
effects by suppressing the activation of macrophages.
The molecular mechanism bywhich SF exerts anti-inﬂammatory
responses was next examined in macrophages. It is well known that
inﬂammatory responses in macrophages are dominantly mediated
by the activation of several signal transductionpathways, such asNF-
kB, AP-1, and IRF3 signaling pathways [3,4,29e31]. To examine
whether KRG-WE, KRG-NSF, and KRG-SF play a role in modulating
the transcriptional activities of NF-kB, AP-1 and IRF3, a luciferase
reporter gene assay was used using NF-kB-Luc, AP-1-Luc, and IRF3-) splenocytes were treated with the indicated concentration of KRG-WE, KRG-NSF, and
compared to normal controls. KRG-NSF, Korean Red Ginseng nonsaponin fraction; KRG-
, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.
Fig. 3. Effects of KRG-WE, KRG-NSF, and KRG-SF on NO production, mRNA expression, and phagocytic activity. (A) RAW264.7 cells were pretreated with the indicated concentration
of KRG-WE, KRG-NSF, KRG-SF, or L-NAME and incubated with LPS (1 mg/mL) for 24 h. NO production was determined by Griess assay using culture supernatants of the cells. (B)
RAW264.7 cells were pretreated with KRG-WE, KRG-NSF, and KRG-SF (200 mg/mL) and incubated with LPS (1 mg/mL) for 6 h. mRNA levels of iNOS, COX-2, TNF-a, and IFN-b were
determined by semiquantitative PCR. (C) RAW264.7 cells were pretreated with KRG-WE, KRG-NSF, and KRG-SF (200 mg/mL) and incubated with FITC-dextran (1 mg/mL) for 30 min.
The uptake levels of FITC-dextran were measured by ﬂow cytometry. *p < 0.05 and **p < 0.01 compared to controls. COX-2, cyclooxygenase-2; FITC, ﬂuorescein isothiocyanate; IFN,
interferon; KRG-NSF, Korean Red Ginseng nonsaponin fraction; KRG-SF, Korean Red Ginseng saponin fraction; KRG-WE, Korean Red Ginseng water extract; L-NAME, Nu-nitro-L-
arginine methyl ester; LPS, lipopolysaccharide; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; NO, nitric oxide; PCR, polymerase chain reaction; TNF, tumor
necrosis factor.
K.-S. Baek et al / Effects of KRG-derived components 441Luc constructs in HEK293 cells. KRG-WE, KRG-NSF, and KRG-SF
markedly suppressed the luciferase activities of IRF3 induced by
TBK1 inHEK293 cells (Fig. 4A),whereasKRG-WE,KRG-NSF, andKRG-
SF failed to signiﬁcantlymodulate the luciferase activities of bothNF-
kB and AP-1 induced by MyD88 (Figs. 4B and 4C). Because KRG-WE,
KRG-NSF, and KRG-SF suppressed the luciferase activity of IRF3, we
further examined whether they could decrease the nuclear trans-
location of IRF3 in RAW264.7 cells. As expected, KRG-WE, KRG-NSF,
and KRG-SF decreased the nuclear translocation of phospho-IRF3
induced by LPS in RAW264.7 cells (Fig. 4D). Interestingly, and in
accordance with the results of the luciferase gene assay, only SF
dramatically decreased the nuclear translocation of phospho-IRF3 in
RAW264.7 cells (Fig. 4D). To investigatewhich intracellular signaling
molecules are involved in the IRF3 signaling pathways suppressed by
KRG-WE, KRG-NSF, and KRG-SF, LPS-stimulated RAW264.7 cells
were treated with KRG-WE, KRG-NSF, or KRG-SF, and changes in the
activity of TBK1 (located upstream of IRF3) were determined. Thephosphorylation of TBK1 induced by LPS was not detectable in the
RAW264.7 cells treated with KRG-SF, whereas the phosphorylation
levels of TBK1 in the RAW264.7 cells treated with KRG-WE or KRG-
NSF were comparable (Fig. 4E). KRG-WE and KRG-NSF suppressed
the nuclear translocation of IRF3 (Fig. 4D), but they did not decrease
the phosphorylation levels of TBK1 (Fig. 4E), suggesting that the
molecular mechanisms of the SF-mediated anti-inﬂammatory ef-
fects differ from those of KRG-WE and KRG-NSF. KRG-SF exerts its
anti-inﬂammatory effects by inhibiting the activity of TBK1 and
suppressing the nuclear translocation and transcriptional activity of
its downstream molecule, IRF3. In contrast, KRG-WE and KRG-NSF
exert their anti-inﬂammatory effects by suppressing the nuclear
translocation and transcriptional activity of IRF3, and by inhibiting
molecules upstream of IRF3 (rather than TBK1) in macrophages.
Although in vitro and ex vivo studies support the anti-
inﬂammatory effects of KRG-WE, KRG-NSF, and KRG-SF, and pro-
vide the molecular and cellular mechanisms of their anti-
Fig. 4. Effects of KRG-WE, KRG-NSF, and KRG-SF on activation of IRF3, NF-kB, and AP-1 pathways. HEK293 cells transfected with the following constructs for 36 h were treated with
KRG-WE, KRG-NSF, and KRG-SF (200 mg/mL) for 12 h. (A) IRF3-Luc and TBK1 expression constructs. (B) NF-kB-Luc and MyD88 expression constructs. (C) AP-1-Luc and MyD88
expression constructs. Luciferase activities were measured using a luminometer. (D) RAW264.7 cells pretreated with KRG-WE, KRG-NSF, and KRG-SF (200 mg/mL) were further
incubated with LPS (1 mg/mL) for 30 min, after which the level of phosphorylated IRF3 was determined by Western blot analysis. (E) RAW264.7 cells pretreated with KRG-WE, KRG-
NSF, and KRG-SF (200 mg/mL) were further incubated with LPS (1 mg/mL) for 5 min, after which the level of phosphorylated TBK1 was determined byWestern blot analysis. *p<0.05,
**p <0.01 compared with control cells. AP-1, activator protein-1; IRF3, interferon regulatory factor 3; KRG-NSF, Korean Red Ginseng nonsaponin fraction; KRG-SF, Korean Red
Ginseng saponin fraction; KRG-WE, Korean Red Ginseng water extract; LPS, lipopolysaccharide; NF-kB, nuclear factor kappa B; NO, nitric oxide; PCR, polymerase chain reaction; TNF,
tumor necrosis factor.
J Ginseng Res 2016;40:437e444442inﬂammatory roles in macrophages, a study regarding their in vivo
anti-inﬂammatory roles in animal models of inﬂammatory diseases
is also critical for the development of efﬁcacious and safe drugs to
treat inﬂammatory diseases. The in vivo anti-inﬂammatory effects of
KRG-WE, KRG-NSF, and KRG-SF were explored during acute experi-
mental gastritis induced in mice by injecting HCl/EtOH. Because
previous studies have revealed that oral administration of ginseng or
its metabolites/derivatives is a reasonable route to test their in vivo
anti-inﬂammatory effects in animal models [19,32,33], KRG-WE,
KRG-NSF, and KRG-SF were orally administered in the HCl/EtOH-
induced gastritis mice, and their anti-inﬂammatory activities were
examined according to the time schedule described in Fig. 5A. KRG-
WE, KRG-NSF, andKRG-SFameliorated the symptoms of gastric ulcer
(Fig. 5B) and signiﬁcantly reduced the area of the disease lesions
(Fig. 5C) in the HCl/EtOH-induced experimental gastritis mice. Theseresults strongly suggest that oral administration of KRG-WE, KRG-
NSF, andKRG-SF could be a potential and effective anti-inﬂammatory
remedy to treat gastritis.
In summary, we found that KRG-WE, KRG-NSF, and KRG-SF
exhibited in vivo and in vitro anti-inﬂammatory effects by amelio-
rating the symptoms of gastric ulcer in the gastritismousemodel and
by suppressing the IRF3 signaling pathway in macrophages. Inter-
estingly, although KRG-WE, KRG-NSF, and KRG-SF exerted in vitro
anti-inﬂammatory effects by suppressing the IRF3 signaling pathway
in macrophages, the activity of TBK1 was reduced only by KRG-SF,
but not by KRG-WE and KRG-NSF. In addition, although KRG-SF
decreased phagocytic activity, NO production, and mRNA expres-
sion of inﬂammatory genes in inﬂammatory macrophages, KRG-NSF
may exert an in vivo anti-inﬂammatory activity by a mechanism
other than the modulation of macrophage-mediated inﬂammatory
Fig. 5. Effects of KRG-WE, KRG-NSF, and KRG-SF on HCl/EtOH-induced inﬂammatory symptoms in mouse stomachs. (A) Time schedule for evaluating the anti-inﬂammatory effects
of KRG-WE, KRG-NSF, and KRG-SF in the HCl/EtOH-induced gastritis mouse model. (B) Mice were orally administered KRG-WE, KRG-NSF, KRG-SF (200 mg/kg), or ranitidine (RNT, 40
mg/kg) three times prior to the oral administration of HCl/EtOH. After 1 h, gastric lesions in the stomachs were photographed. (C) Gastric lesions were measured with a pixel
counter. The gastric lesions of the control group (inducer alone) are represented by 100%. *p <0.05 and **p <0.01 compared with control cells. EtOH, ethanol; KRG-NSF, Korean Red
Ginseng nonsaponin fraction; KRG-SF, Korean Red Ginseng saponin fraction; KRG-WE, Korean Red Ginseng water extract.
K.-S. Baek et al / Effects of KRG-derived components 443responses. Exactly how KRG-NSF plays an anti-inﬂammatory role in
macrophages needs to be further investigated. Our data strongly
suggest that KRG-WE, KRG-NSF, and KRG-SF have anti-inﬂammatory
activities with different molecular and cellular mechanisms, and
could therefore be developed as potential anti-inﬂammatory rem-
edies to prevent and treat inﬂammatory diseases.
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